UCTV Documentary Features UCSF in "A Dose of Hope" for Parkinson's Patients
A documentary debuting today shows how UCSF researchers are using innovative multidisciplinary treatment strategies for patients living with Parkinson’s disease.
University of California San Francisco
Give to UCSFA documentary debuting today shows how UCSF researchers are using innovative multidisciplinary treatment strategies for patients living with Parkinson’s disease.
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
African Americans, the foreign-born, and the near-poor are more likely to encounter barriers to being treated at a trauma center, according to new research reports by UCSF emergency medicine physician and researcher Renee Hsia, and her colleagues.
A medication commonly prescribed as a muscle relaxant shows promise as a potential treatment for alcoholism, based on a study in rats by researchers at the Ernest Gallo Clinic and Research Center and the University of California, San Francisco.
UCSF will celebrate the opening of a new Teaching and Learning Center at the Parnassus from January 18 to 21.
<p>John Roberts, chief of the UCSF Transplant Service, talks about the risks and benefits of living donor liver transplants in a recent interview.</p>
Parkinson’s disease researcher Robert Nussbaum, a human geneticist and neuroscientist at UCSF, has been named to receive the prestigious Klaus Joachim Zülch Neuroscience Prize for 2011.
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.
Seven of UCSF’s health care experts will share their wisdom on Wednesday during the cloud computing conference known as Dreamforce 2010 at San Francisco’s Moscone Center.
Richard Abbott, MD, won an award for excellence in ophthalmology in the Asia-Pacific region following work to promote uniform global standards for eye care.
UCSF’s Stanley Prusiner, who received the National Medal of Science from President Barack Obama on Wednesday, urges today’s students to become the next generation of scientists.
UCSF researchers have for the first time shown that an external optical pacemaker can be used in a vertebrate to control its heart rate.
UCSF Nobel laureate Stanley Prusiner, MD, and colleagues have called for Congress to more than quadruple annual federal funding for Alzheimer’s research, saying that with a dedicated effort, there is a chance for a breakthrough against the disease by 2020.
A tiny, translucent juvenile zebrafish, on the hunt for even littler prey, has offered up a big insight into how a specific circuit of nerve cells functions in the brain.
Researchers at the Ernest Gallo Clinic and Research Center at UCSF, and Pfizer Inc., have determined that two new compounds may be effective in treating both alcohol and nicotine dependence at the same time.
Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents.
As the World Series is set to kick off tonight, a couple Giants baseball legends paid a special visit to some of their smallest fans at UCSF Benioff Children’s Hospital.
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
UCSF Nobel laureate Stanley B. Prusiner, professor of neurology and director of the Institute for Neurodegenerative Diseases, today (Oct. 15, 2010) was named to receive the National Medal of Science, the nation’s highest honor for science and technology.
Synuclein is a protein that can cause Parkinson’s disease, although it is not clear how. UCSF researcher Robert Edwards, MD, now has discovered that synuclein can affect signal transmission between nerve cells long before disease symptoms arise.
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.
UCSF research-doctorate programs have ranked among the nation’s best in a survey released today by the National Research Council (NRC).
An inexpensive, hundred-year-old therapy for pain – aspirin – is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.